Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Stress Prevention and Stress Management Techniques IV

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...

Binge Eating Disorders

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Projected health benefits and cost offsets from the United States National Hepatitis C Elimination Initiative.

Nature communications·2026

Same author

Edwardsiella ictaluri infection in farmed striped catfish Pangasianodon hypophthalmus in India : E. ictaluri in Indian aquaculture.

Veterinary research communications·2026

Same author

The new vision from the National Institute of Allergy and Infectious Diseases (NIAID).

Nature medicine·2026

Same author

Assessing the Case Against Direct-to-Consumer Drug Advertisements.

JAMA health forum·2025

Same author

Investigating the know-do gap in antibiotics prescribing: Experimental evidence from India.

Science advances·2025

Same author

The association between baseline physical and mental health and the risk of postacute sequelae of COVID-19 infection.

Scientific reports·2025

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Who pays for obesity?

Jay Bhattacharya¹, Neeraj Sood

¹Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, California, USA.

The Journal of Economic Perspectives : a Journal of the American Economic Association

|May 24, 2011

Summary

Adult obesity is a growing public health concern. Research suggests obese individuals generally bear the costs and benefits of their lifestyle, questioning the need for public policy based on external costs.

Area of Science:

Public Health
Health Economics

Background:

Adult obesity prevalence has nearly tripled between 1962 and 2006.
Obesity affects all socioeconomic groups and is a global issue.

Purpose of the Study:

To empirically analyze who bears the costs and benefits associated with adult obesity.
To evaluate the justification for public policy interventions aimed at reducing obesity.

Main Methods:

Estimation of lifetime costs associated with obesity.
Analysis of labor market and health insurance market impacts on obese individuals.
Examination of externalities, including potential positive externalities of higher body weight.

Main Results:

Existing literature suggests obese individuals, on average, bear the costs and benefits of their health behaviors.

More Related Videos

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Published on: June 21, 2019

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Related Experiment Videos

Last Updated: Jun 1, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Published on: June 21, 2019

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

The study explores the role of private health insurance in pooling risks and its potential influence on obesity.

Consideration of whether obesity confers positive externalities on non-obese populations.

Conclusions:

Public policy for obesity reduction may not be justified by external costs imposed on others.
Alternative justifications for policy, such as addressing ignorance or self-control issues, require further complex consideration.